VVN432 nasal spray

VVN432 · VivaVision Biotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VVN432 nasal spray, covering 2025-12-02 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study Evaluating the Safety, Tolerability, and Pharmacokinetics of VVN432 Nasal Spray [Phase 1]